Closing Bell: Knight Therapeutics Inc up on Monday (GUD)

Today in trading, Knight Therapeutics Inc opened at $5.72 and closed at $5.86. It traded at a low of $5.72 to a high of $5.86.

Shares advanced 2.45 percent from the previous day's close of $5.72.

During the day across North America, the TSX Composite closed 0.57% at 22673.52, the S&P 500 closed 0.55% at 5615.35, the Dow Jones Industrial Average closed 0.62% at 40000.90 and the Nasdaq Composite closed 0.63% at 18398.45.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 39,307 shares was traded during the last trading day, with total trades of 246, with an average volume of 53,947 over 5 days.

The TSX overall saw 3,258 price advancers against 1,978 declines and 100 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 20.08% in the last 52 weeks, while they have boosted 12.91% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $579.87 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..